Browsing by Author Cooper, Wendy

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2014Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanomaCarlino, Matteo; Hamilton, Anne; Haydu, Lauren; Kakavand, Hojabr; Kefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; O'Toole, Sandra; Scolyer, Richard; Thompson, John; Yu, Bing; Cooper, Wendy; Ng, C; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: MedicineCorrelation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma, British Journal of Cancer, vol.111, 2, 2014,pp 292-299
2013EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinomaGill, Anthony; Horvath, Lisa; McCaughan, Brian; O'Toole, Sandra; Trent, Ronald; Yip, Po Yee; Yu, Bing; Clarkson, A; Cooper, Wendy; Farzin, M; Kench, James; Kohonen-Corish, Maija R.J.; Lum, Trina; Mercorella, B; Ng, Chiu Chin; Deans Unit: (CIPHER); Central Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Medicine; Medicine; Central Clinical School: MedicineEGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma, Journal of Clinical Pathology (JCP Online), vol.66, 9, 2013,pp 744-748
2013Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancerMcCaughan, Brian; O'Toole, Sandra; Cooper, Wendy; Kennedy, Catherine; Kohonen-Corish, Maija R.J.; Selinger, Christina; Tran, Thang N.; Central Clinical School: Surgery; Central Clinical School: PathologyFibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer, Lung Cancer, vol.81, 3, 2013,pp 462-467
2012Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancerMcCaughan, Brian; Poursoltana, Pirooz; Trent, Ronald; Cooper, Wendy; Currey, N; Kennedy, Catherine; Kohonen-Corish, M.R.J.; Mahar, Annabelle; Pangon, Laurent; Selinger, Christina; van Kralingen, Christa; Central Clinical School: Surgery; Northern Clinical School: Medicine; Central Clinical School: MedicineLoss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer, Lung Cancer, vol.77, 2, 2012,pp 272-276
2011Loss of Special AT-Rich Binding Protein 1 Expression is a Marker of Poor Survival in Lung CancerMcCaughan, Brian; Al-Sohaily, Sam; Cooper, Wendy; Kennedy, C T; Kohonen-Corish, M.R.J.; Mladenova, Dessislava; Pangon, Laurent; Selinger, Christina; Stirzaker, Clare; Central Clinical School: SurgeryLoss of Special AT-Rich Binding Protein 1 Expression is a Marker of Poor Survival in Lung Cancer, Journal of Thoracic Oncology, vol.6, 7, 2011,pp 1179-1189
2013Patterns of DNA mutations and ALK Rearrangement in Resected Node Negative Lung AdenocarcinomaBoyer, Michael; Horvath, Lisa; Kench, James; McCaughan, Brian; O'Toole, Sandra; Trent, Ronald; Yip, Po Yee; Yu, Bing; Cooper, Wendy; Kennedy, Catherine; Kohonen-Corish, Maija R.J.; Ng, Chiu Chin; Selinger, Christina; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Medical Sciences: Pathology; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Medicine; Medicine; Central Clinical School: MedicinePatterns of DNA mutations and ALK Rearrangement in Resected Node Negative Lung Adenocarcinoma, Journal of Thoracic Oncology, vol.8, 4, 2013,pp 408-414
2014Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancerBoyer, Michael; Horvath, Lisa; Kench, James; McCaughan, Brian; Yip, Po Yee; Cooper, Wendy; Kohonen-Corish, Maija R.J.; Lin, Betty P.C.; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Medical Sciences: Pathology; Central Clinical School: Surgery; MedicinePhosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer, Journal of Clinical Pathology, vol.67, 4, 2014,pp 333-340
2013Testing for ALK rearrangement in lung adenocarcinoma: A multicenter comparison of immunohistochemistry and fluorescent in situ hybridizationBoyer, Michael; Horvath, Lisa; O'Toole, Sandra; Yip, Po Yee; Cooper, Wendy; Fox, Stephen B.; Kohonen-Corish, Maija R.J.; McCaughan, Brian; Rogers, Toni-Maree; Russell, Prudence; Selinger, Christina; Solomon, Benjamin; Wainer, Zoe; Wright, Gavin; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Pathology; MedicineTesting for ALK rearrangement in lung adenocarcinoma: A multicenter comparison of immunohistochemistry and fluorescent in situ hybridization, Modern Pathology, vol.26, 12, 2013,pp 1545-1553
2011What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangementsBoyer, Michael; Horvath, Lisa; O'Toole, Sandra; Cooper, Wendy; Mahar, Annabelle; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: PathologyWhat's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements, Pathology, vol.43, 2, 2011,pp 103-115